Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (STLNW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

$5.29M

MomentumView details →

1D Return

−23.33%

YTD Return

—

RSI (14)

50.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

$5.29M

RSI (14)

50.0

MomentumView details →

1D Return

−23.33%

YTD Return

—

ProfitabilityView details →

Gross Margin

15.69%

Net Margin

−6.18%

EBITDA Margin

−3.28%

ROE (TTM)

145.67%

ROA (TTM)

−20.36%

Asset Turnover

3.39x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+25.81%

EPS CAGR 3Y

+23.94%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−$0.05

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

−4.21x

Current Ratio

1.36x

Quick Ratio

1.15x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

587.24M

Net Income (TTM)

−36.29M

Op. CF (TTM)

328000.00

Next earningsNov 11, 2026 →

Latest newsMore news →

No recent news for STLNW.

Similar companies

ModivCare Inc.MODV Syra Health Corp. Class A Common StockSYRA Mobile-health Network Solutions Class A Ordinary SharesMNDR RMH Holdings Limited08437.HK MediNet Group Limited08161.HK Concord Medical Services Holdings LimitedCCM Find similar companies →

Latest newsMore news →

No recent news for STLNW.